此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

The Effect of Blood Pressure on Cerebral Perfusion During Vascular Surgery

2017年9月26日 更新者:Niels Damkjær Olesen、Rigshospitalet, Denmark

The Effect of Blood Pressure on Cerebral Perfusion and Oxygenation During Vascular Surgery

Anesthesia reduces blood pressure and cerebral blood flow is normally considered to be maintained despite marked changes in blood pressure. Vascular surgical patients are often elderly, have high blood pressure and atherosclerosis and in these patients cerebral blood flow may decrease if blood pressure is reduced during anesthesia. The purpose of this study is to assess the effect of blood pressure for preservation of cerebral blood flow during anesthesia in vascular surgery. The hypothesis is that in vascular surgical patients, during anesthesia, cerebral blood flow is higher with blood pressure maintained at a higher level than that used in normal clinical practice.

研究概览

详细说明

Background: Induction of anesthesia reduces mean arterial pressure (MAP) and cerebral blood flow is normally considered to be maintained by cerebral autoregulation despite changes in MAP between 60 - 150 mmHg and standard of care during anesthesia is to maintain MAP above 60 mmHg. Vascular surgical patients are often elderly with hypertension and atherosclerotic manifestations that may impair cerebral autoregulation of importance for anesthesia-induced reduction in blood pressure.

Objective: To assess the effect of MAP for preservation of cerebral blood flow and oxygenation during vascular surgery.

Hypothesis: The primary hypothesis is that during general anesthesia in vascular surgical patients, cerebral blood flow velocity and oxygenation is higher with MAP maintained at 80-90 mmHg, compared with a MAP maintained at a minimum of 60 mmHg.

MAP is controlled in both groups using continuous infusion of phenylephrine. Phenylephrine is used as a tool in order to assess the effect of MAP on the cerebral circulation. In both groups, central blood volume is optimized by infusion of lactated Ringer´s solution using a goal directed fluid therapy following induction of anaesthesia and before commencement of phenylephrine infusion.

Trial size: The investigators will include 40 participants (2 x 20) in order to detect or reject a 20% difference in middle cerebral artery velocity with a type I error risk of 5% and a type II error risk of 20% (power at 80%). Interim analysis will be conducted after inclusion of 20 patients (2 x 10). Excluded patients will be replaced.

研究类型

介入性

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Copenhagen Ø、丹麦、2100
        • Rigshospitalet, Anæstesi og Operationsklinikken 2043

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

19年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Patients undergoing one of the following vascular surgical interventions in general anesthesia: Infra-inguinal bypass, femoro-femoral cross-over bypass or iliofemoral bypass surgery.
  • Age > 18 years. Informed consent

Exclusion Criteria:

  • Use of monoamine oxidase inhibitors
  • Allergy to phenylephrine
  • Patients that cannot cooperate during examination
  • Dementia defined as Mini-Mental State Examination < 24
  • Anesthesia within the last 30 days
  • Alcohol consumption at or above 420 grams per week
  • Lack of fluency in written and spoken Danish
  • Severe hearing and vision impairment
  • Neurological disease

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
实验性的:MAP maintained at 80 mmHg
During anesthesia MAP is maintained at 80 - 90 mmHg MAP using continuous infusion of phenylephrine.
Intervention group, MAP is maintained at 80 - 90 mmHg during anesthesia using continuous infusion of phenylephrine.
有源比较器:MAP maintained at 60 mmHg
During anesthesia MAP is maintained at minimum of 60 mmHg using continuous infusion of phenylephrine.
Control group, MAP is maintained at minimum of 60 mmHg during anesthesia using continuous infusion of phenylephrine.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Middle cerebral artery blood velocity
大体时间:During surgery
Middle cerebral artery blood velocity measured in [cm/s] assessed by transcranial Doppler. Changes in middle cerebral artery blood velocity reflects changes in cerebral blood flow.
During surgery

次要结果测量

结果测量
措施说明
大体时间
Change in serum S100B as compared between subjects in the control- and intervention groups
大体时间:Blood is sampled 10 min prior to induction of anesthesia and at the end of surgery
Serum concentrations of S100B, a marker of neuronal injury
Blood is sampled 10 min prior to induction of anesthesia and at the end of surgery
Change in serum neuron-specific enolase as compared between subjects in the control- and intervention groups
大体时间:Blood is sampled 10 min prior to induction of anesthesia and at the end of surgery
Serum concentrations of neuron-specific enolase, a marker of neuronal injury
Blood is sampled 10 min prior to induction of anesthesia and at the end of surgery
Regional cerebral oxygenation as compared between subjects in the control- and intervention groups
大体时间:During surgery
Frontal lobe oxygenation measured as the percentage of oxyhemoglobin of total hemoglobin [%] evaluated by near-infrared spectroscopy
During surgery
Cardiac output as compared between subjects in the control- and intervention groups
大体时间:During surgery
Cardiac output measured in [l/min] evaluated by pulse contour analysis of the arterial blood pressure curve
During surgery
Stroke volume as compared between subjects in the control- and intervention groups
大体时间:During surgery
Stroke volume measured in [ml/min] evaluated by pulse contour analysis of the arterial blood pressure curve
During surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Niels D. Olesen, MD、Rigshospitalet, Anæstesi og Operationsklinikken 2043, Denmark

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (预期的)

2017年3月1日

初级完成 (预期的)

2017年11月1日

研究完成 (预期的)

2017年11月1日

研究注册日期

首次提交

2015年8月14日

首先提交符合 QC 标准的

2015年8月20日

首次发布 (估计)

2015年8月24日

研究记录更新

最后更新发布 (实际的)

2017年9月28日

上次提交的符合 QC 标准的更新

2017年9月26日

最后验证

2017年9月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

在美国制造并从美国出口的产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

MAP maintained at 80 mmHg的临床试验

3
订阅